Rani Therapeutics Hldgs RANI will release its quarterly earnings report on Monday, 2025-03-31. Here's a brief overview for ...

Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company ...

March 25, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of ...

Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on Rani Therapeutics Holdings (RANI – Research Report) today and set a price ...

Rani Therapeutics (RANI) announced pharmacokinetic and pharmacodynamic data from a preclinical study evaluating RT-114, a GLP-1/GLP-2 dual ...

Shares of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) have received a consensus rating of “Buy” from the six ratings firms that are covering the stock, Marketbeat reports.

SAN JOSE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...